Immune Response To Intranasal Influenza Vaccination

NAActive, not recruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

October 1, 2012

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions

Tonsillitis, Hypertrophy

Interventions

DRUG

FLUENZ

live attenuated influenza vaccine

Trial Locations (1)

Haukeland University Hospital, Bergen

All Listed Sponsors

collaborator

Haukeland University Hospital

OTHER

lead

University of Bergen

OTHER

NCT01866540 - Immune Response To Intranasal Influenza Vaccination | Biotech Hunter | Biotech Hunter